Dysmenorrhea Clinical Trial
Official title:
The Study of Efficacy and Effect of Different Dose Acupuncture on Autonomic Nervous Activity and Quality of Life in Women With Dysmenorrhea
Verified date | July 2018 |
Source | Taipei City Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Subjects in this study included premenstrual syndrome and dysmenorrhea.
Premenstrual syndrome (PMS) is the sum of a group of symptoms (including physical and
psychological symptoms) that occurs during the luteal phase of the menstrual cycle.
Dysmenorrhea is a sort of period pelvic pain, caused by blood flow decrease abruptly and
ischemia due to frequent contraction of the uterus.
In clinical practice, gynecologists apply analgesic such as Non-steroidal Anti- inflammatory
Drugs (NSAIDs), and oral contraceptive pills (OCT) or progestin as conventional therapy for
premenstrual syndrome and dysmenorrhea. As NSAIDs may cause gastrointestinal discomfort,
dyspepsia while hormone therapy leads to other concerns; some women now adopt acupuncture as
an alternative therapy for its safety. However, many parameters affect the efficacy of
acupuncture, such as the sorts of acupoints (of which meridians) or the numbers of acupoints;
and proper evidence-based medicine on this issue is few.
Therefore, in this study, we aim to evaluate 1. The different impact of acupuncture and
conventional therapy in premenstrual syndrome and dysmenorrhea women ; 2. Will the character
(of which meridians) or numbers of acupoints be affecting factors of efficacy in treating
premenstrual syndrome and dysmenorrhea? 3. Shall there be any relationship between the
acupuncture and autonomic nerve activity adjustment in premenstrual syndrome and
dysmenorrhea? 4. Shall there be any relationship between the acupuncture and TCM syndrome
adjustment in premenstrual syndrome and dysmenorrhea?
Status | Enrolling by invitation |
Enrollment | 105 |
Est. completion date | December 31, 2019 |
Est. primary completion date | December 31, 2019 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 19 Years to 49 Years |
Eligibility |
Inclusion Criteria: 1. Women within reproductive age (15 to 49 years) 2. VAS?4 3. Women with a history of regular menstrual cycles (28days±7 days) 4. Self-reported lower abdominal and pelvic, medial anterior thigh pain or low back pain associated with the onset of menses and lasting in 72 hours. 4.Symptoms: dysmenorrhagia, breast pain, dizziness, bloating, cramps, nausea, vomiting, diarrhea, headache, fatigue, etc. Exclusion Criteria: 1. Women with irregular menstrual cycles 2. Women use of an intrauterine contraceptive device (IUCD/IUD) 3. Women with uncontrolled neurological diseases 4. Lactation, pregnant women, or those with plans to get pregnant in the coming half year |
Country | Name | City | State |
---|---|---|---|
Taiwan | Taipei City H | Taipei |
Lead Sponsor | Collaborator |
---|---|
Taipei City Hospital |
Taiwan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Wang Qi Chinese Medicine Questionnaire | This questionnaire is used to survey TCM constitutions. Evaluate body constitution of each individual by score(Balanced Constitution, Qi-deficient Constitution, Yang-deficient Constitution, Yin-deficient Constitution, Phlegm-dampness Constitution, Damp-heat Constitution, Stagnant Blood Constitution, Stagnant Qi Constitution, and Inherited Special Constitution). | We will evaluate separately at baseline and the end of cycle 4 (each cycle is 30 days). Change from Baseline TCM constitutions at 4 cycles (each cycle is 30 days). Time Frame: baseline and 4 cycles (each cycle is 30 days) | |
Primary | Heart rate variation (HRV) test | HRV test include time domain analysis and frequency domain analysis.Time domain analysis includes SDNN, R-MSSD and pNN50. Frequency domain analysis includes LF, HF, LF/HF and total power. | We will evaluate separately at baseline and the end of cycle 4 (each cycle is 30 days). Change from Baseline HRV parameter at 4 cycles (each cycle is 30 days). Time Frame: baseline and 4 cycles (each cycle is 30 days) | |
Secondary | Visual analogue scale(VAS) score | VAS is used to assess the extent of menstrual pain. | We will evaluate separately at baseline and the end of cycle 4 (each cycle is 30 days). Change from Baseline VAS score at 4 cycles (each cycle is 30 days). Time Frame: baseline and 4 cycles (each cycle is 30 days) | |
Secondary | Verbal multidimensional scoring system (VMSS) assessment | VMSS is used to assess the severity of dysmenorrhea. The VMSS assessment ranges from zero, one, two and three grade for evaluating the working ability, the systemic symptoms and whether analgesia is required or not. Grade 0 indicates that menstruation is not painful and daily activity is unaffected. Grade 1 indicates that menstruation is painful but seldom inhibits normal activity; analgesics are seldom required; mild pain. Grade 2 indicates that daily activity is affected; analgesics required and give sufficient relief so that absence from school is unusual; moderate pain. Grade 3 indicates that activity clearly inhibited; poor effect of analgesics; vegetative symptoms (headache, fatigue, vomiting, and diarrhea); severe pain. |
We will evaluate separately at baseline and the end of cycle 4 (each cycle is 30 days). Change from Baseline VMSS assessment at 4 cycles (each cycle is 30 days). Time Frame: baseline and 4 cycles (each cycle is 30 days) | |
Secondary | SF-12 Health Survey | SF-12 health survey is a questionnaire used to assess the quality of life of individuals. It contains a total of 12 questions and can be aggregated into physiological facets and psychological facets to assess the physiological and mental health status of the subjects. | We will evaluate separately at baseline and the end of cycle 4 (each cycle is 30 days). Change from Baseline SF-12 Health Survey at 4 cycles (each cycle is 30 days). Time Frame: baseline and 4 cycles (each cycle is 30 days) | |
Secondary | Blood test | Contain:estrogen, progesterone and prostaglandin | We will evaluate separately at baseline and the end of cycle 4 (each cycle is 30 days). Change from Baseline blood test at 4 cycles (each cycle is 30 days). Time Frame: baseline and 4 cycles (each cycle is 30 days) | |
Secondary | Menstrual Distress Questionnaire(MDQ) | Contain: Pain;Concentration;Behavioral Change;Autonomic Reactions;Water Retention;Negative Affect | We will evaluate separately at baseline and the end of cycle 4 (each cycle is 30 days). Change from Baseline Menstrual Distress Questionnaire at 4 cycles (each cycle is 30 days). Time Frame: baseline and 4 cycles (each cycle is 30 days) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04607382 -
Survey on Menstrual Symptoms, Health Related Quality of Life and Work Productivity in Patients Suffering From Pain During Menstruation (Dysmenorrhea) in Japan
|
||
Recruiting |
NCT04091789 -
Sublingual Tablets With Cannabinoid Combinations for the Treatment of Dysmenorrhea
|
Phase 2 | |
Completed |
NCT00769964 -
VA111913 TS: First in Human Study
|
Phase 1 | |
Completed |
NCT00746096 -
Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat Primary Dysmenorrhea
|
Phase 3 | |
Completed |
NCT00104546 -
Vitamin K Injections for the Treatment of Painful Menstruation
|
Phase 1 | |
Completed |
NCT06011928 -
MOPEXE and RE in Treating Dysmenorrhea
|
N/A | |
Not yet recruiting |
NCT06398990 -
The Effect of Cognitive Exercise Therapy Approach and Yoga in Adolescents With Dysmenorrhoea
|
N/A | |
Recruiting |
NCT02031523 -
Multi-center Clinical Trials of Sanjie Analgesic Capsule in Treating Endometriosis
|
Phase 4 | |
Completed |
NCT01449305 -
Effectiveness of Nanoone Woman Underwear Using in the Management of Dysmenorrhea
|
N/A | |
Completed |
NCT00995917 -
A Pilot Study of Acupoint Injection for Primary Dysmenorrhea
|
N/A | |
Completed |
NCT02910167 -
Observational Prospective Study to Evaluate AEs, Risk Factors and Drug Utilization of BUSCAPINA COMPOSITUM N in Adults From Metropolitan Lima
|
||
Not yet recruiting |
NCT05461846 -
Effect of Integrated Neuromuscular Inhibition Technique in Females With Menstrual Low Back Pain
|
N/A | |
Completed |
NCT05247333 -
Implementation of a Minor Ailment Service in Community Pharmacy Practice
|
N/A | |
Not yet recruiting |
NCT03697746 -
Comparison of Dexketoprofen, Paracetamol and Ibuprofen in the Treatment of Primary Dysmenorrhea
|
N/A | |
Recruiting |
NCT03394547 -
Pulsed Electromagnetic Field Treatment for Painful Periods
|
N/A | |
Recruiting |
NCT06294743 -
Posterior Tibia Nerve Neuroprolotherapy for Dysmenorrhea
|
Early Phase 1 | |
Active, not recruiting |
NCT01738204 -
The Women's Health Study: From Adolescence to Adulthood
|
||
Completed |
NCT01462370 -
Study to Assess the Safety and Efficacy of Etoricoxib Versus Ibuprofen in the Treatment of Dysmenorrhea (MK-0663-145 AM1)
|
Phase 3 | |
Completed |
NCT01250587 -
Dose-Finding Study of PDC31 in Patients With Primary Dysmenorrhea
|
Phase 1 | |
Completed |
NCT00951561 -
A Comparison Study of Pain Relief From Dysmenorrhea Between the Vipon Tampon and Ibuprofen
|
N/A |